Caliciviridae Infections: Clinical Trials

2 trials for Caliciviridae Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 21Completed 1

Follow Caliciviridae Infections: new trials by email Literature Review of Caliciviridae Infections trials Research Report on Caliciviridae Infections

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula Polymorpha)
Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula polymorpha), placebo - Norovirus Infections, Norwalk Gastroenteritis
Phase 3CompletedNational Vaccine and Serum Institute, China80002023-06-302026-01-16
Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children
Alinia (nitazoxanide) - Rotavirus Infection, Adenoviridae Infection
Phase 2 / Phase 3CompletedRomark Laboratories L.C.502005-02-012012-05-31

Narrower conditions

Adenoviridae Infections (1)  ·  Rotavirus Infections (1)

Broader conditions

Infections (2)  ·  RNA Virus Infections (2)  ·  Virus Diseases (2)  ·  DNA Virus Infections (1)  ·  Reoviridae Infections (1)

Interventions

nitazoxanide (1)

Sponsors

National Vaccine and Serum Institute, China (1)  ·  Romark Laboratories L.C. (1)

Countries

China (1)

Top investigators

Mona Abu-Zekry, MD (1)

Results publications

PMID 16829296